Browsing by Author "Revheim, Mona-Elisabeth"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Atherosclerosis Burdens in Diabetes Mellitus: Assessment by PET Imaging
    (MDPI, 2022-09-06) Høilund-Carlsen, Poul F.; Piri, Reza; Madsen, Per Lav; Revheim, Mona-Elisabeth; Werner, Thomas J.; Alavi, Abass; Gerke, Oke; Sturek, Michael; Anatomy, Cell Biology and Physiology, School of Medicine
    Arteriosclerosis and its sequelae are the most common cause of death in diabetic patients and one of the reasons why diabetes has entered the top 10 causes of death worldwide, fatalities having doubled since 2000. The literature in the field claims almost unanimously that arteriosclerosis is more frequent or develops more rapidly in diabetic than non-diabetic subjects, and that the disease is caused by arterial inflammation, the control of which should therefore be the goal of therapeutic efforts. These views are mostly based on indirect methodologies, including studies of artery wall thickness or stiffness, or on conventional CT-based imaging used to demonstrate tissue changes occurring late in the disease process. In contrast, imaging with positron emission tomography and computed tomography (PET/CT) applying the tracers 18F-fluorodeoxyglucose (FDG) or 18F-sodium fluoride (NaF) mirrors arterial wall inflammation and microcalcification, respectively, early in the course of the disease, potentially enabling in vivo insight into molecular processes. The present review provides an overview of the literature from the more than 20 and 10 years, respectively, that these two tracers have been used for the study of atherosclerosis, with emphasis on what new information they have provided in relation to diabetes and which questions remain insufficiently elucidated.
  • Thumbnail Image
    Item
    NaF-PET Imaging of Atherosclerosis Burden
    (MDPI, 2023-01-30) Høilund-Carlsen, Poul F.; Piri, Reza; Gerke, Oke; Sturek, Michael; Werner, Thomas J.; Revheim, Mona-Elisabeth; Alavi, Abass; Anatomy, Cell Biology and Physiology, School of Medicine
    The method of 18F-sodium fluoride (NaF) positron emission tomography/computed tomography (PET/CT) of atherosclerosis was introduced 12 years ago. This approach is particularly interesting because it demonstrates microcalcification as an incipient sign of atherosclerosis before the development of arterial wall macrocalcification detectable by CT. However, this method has not yet found its place in the clinical routine. The more exact association between NaF uptake and future arterial calcification is not fully understood, and it remains unclear to what extent NaF-PET may replace or significantly improve clinical cardiovascular risk scoring. The first 10 years of publications in the field were characterized by heterogeneity at multiple levels, and it is not clear how the method may contribute to triage and management of patients with atherosclerosis, including monitoring effects of anti-atherosclerosis intervention. The present review summarizes findings from the recent 2¾ years including the ability of NaF-PET imaging to assess disease progress and evaluate response to treatment. Despite valuable new information, pertinent questions remain unanswered, not least due to a pronounced lack of standardization within the field and of well-designed long-term studies illuminating the natural history of atherosclerosis and effects of intervention.